# Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma

> **NCT01442324** · NA · UNKNOWN · sponsor: **Azienda Ospedaliera di Padova** · enrollment: 5 (estimated)

## Conditions studied

- Metastatic Liver Cancer
- Cholangiocarcinoma
- Neoplasm Metastasis

## Interventions

- **PROCEDURE:** Irreversible electroporation (IRE)

## Key facts

- **NCT ID:** NCT01442324
- **Lead sponsor:** Azienda Ospedaliera di Padova
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2012-09
- **Final completion:** —
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2012-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01442324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01442324, "Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01442324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*